CENTA is a newly synthesized, beta-lactamase-labile, chromogenic cephalosporin reagent which changes color from light yellow (K maximum ca. 340 nm) to chrome yellow (A maximum ca. 405 nm) concomitant with hydrolysis of the betalactam ring. This compound offers promise as a diagnostic reagent comparable to other chromogens (PADAC and nitrocefin) for the early detection of betalactamase-producing clinical isolates, while retaining some antimicrobial effect against Escherichia coli, Klebsiella spp., Proteus mirabilis, Staphylococcus aureus, and non-enterococcal Streptococcus spp. CENTA is relatively unaffected by commonly used microbiological media and human serum.
CENTA is a newly synthesized chromogenic cephalosporin structurally resembling nitrocefin, cephaloridine, and cephalothin (9; Fig. 1 ). Schindler and colleagues at Hoechst AG have described its physicochemical properties and possible applications to the studies of bacterial beta-lactamases and enzyme inhibitors and measurements of cephalosporin serum concentrations (13, 14; P. Schindler, G. Huber, J. Blumbach, and H. G. Berscheid, Program Abstr. Intersci. Conf. Antimicrob. Agents Chemother. 21st, Chicago, Ill., abstr. no. 434, 1981) . Like PADAC, cephacetrile, and nitrocefin, CENTA seems to offer promise as a diagnostic reagent in the clinical microbiology laboratory, particularly in the early rapid recognition of beta-lactamase production by clinical bacterial isolates (5, 9, 11) . Research applications of such substances have also been accelerated in the quest for betalactamase-stable antimicrobial agents (3, 4, 13) .
In this report we present the in vitro characteristics of CENTA as compared to those previously published for other chromogenic substrates, PADAC and nitrocefin. These investigations included: a comparison of the antimicrobial activity with the two other chromogens; a beta-lactamase hydrolysis rate study of the chromogens and two other reference cephalosporins against eight selected enzyme preparations; the utility of using CENTA, PADAC, or nitrocefin as an enzymelabile substrate in beta-lactamase hydrolysis inhibition studies; and the interaction of CENTA with commonly used microbiological liquid media and with human serum. s32 ij.g/ml). In contrast, none of these species was inhibited by PADAC, and only P. mirabilis was inhibited by nitrocefin (MIC50 = 32 ,ug/ml). All three chromogenic cephalosporins were active against Staphylococcus aureus strains (MIC50 = <0.25 ,ug/ml). PA-DAC demonstrated an anti-staphylococcal activity comparable to the most active of the cephalosporins, e.g., cephalothin and cefamandole (3, 4) . CENTA showed little effect (MIC50 = 128 ,ug/ml) against Streptococcus faecalis as compared to the marginal inhibition demonstrated by PADAC (MIC50 = 16 ,ug/ml) and the excellent activity of nitrocefin (highest MIC = 2.0 ,ug/ml). This latter feature for nitrocefin seems unique among the cephalosporins and was consistent with data reported earlier (5). All three drugs were active against Streptococcus pneumoniae and Streptococcus pyogenes (all MICs, <32 ,ug/ml). The highest MIC for each chromogen was for an S. pneumoniae isolate having a penicillin G MIC of 0.5 ,ug/ml. A marked variation in chromogen MICs was seen between the beta-lactamase-producing Haemophilus influenzae and those strains not exhibiting detectable enzyme. CENTA showed the best anti-Haemophilus activity, generally 16-to 128-fold more potent than either PADAC or nitrocefin. None of these drugs was active against Acinetobacter spp. or the pseudomonads tested.
The results of the cephalosporin substrate relative hydrolysis rate (RHR) studies on eight beta-lactamase preparations are summarized in Table 2 . CENTA undergoes a detectable color change from faint yellow (A maximum 345 nm) to chrome yellow (A maximum 410 nm) concomitant with enzymatic hydrolysis of the beta-lactam ring (Fig. 2) . CENTA appears to be susceptible to all the beta-lactamases tested and comparable to the previously described chromogenic cephalosporins (5, 12, 13; M. H. Richmond, personal communication). The RHR of CENTA was generally 5 to 20% of the nitrocefin reference rates, with the exception of type IV enzyme preparations, for which CENTA exhibited rates close to that of nitrocefin (79 to 81%). The RHR profile of CENTA was thus different from either of the other tested chromogenic reagents and of the compounds tested was most similar to cephalothin. PADAC had more rapid hydrolysis rates than CENTA for enzyme types II, III, and "new" and the new penicillinase derived from B. cereus. CENTA may yield faster positive results than PADAC with enzyme types I and IV, both commonly found in gramnegative clinical isolates. CENTA, PADAC, and cephacetrile (5, 12) all had slower relative hydrolysis rates than nitrocefin. The RHR inhibition profiles (Fig. 3) show CENTA to be somewhat less effective than nitrocefin or PADAC at demonstrating the inhibiting action of beta-lactam drugs on type Ia (P99) beta-lactamase. The differential affinity of these chromogens for the type I enzymes appears to rank in the order: CENTA > nitrocefin > PA-DAC. As an enzyme-labile substrate, CENTA failed to demonstrate any significant inhibitory effect for CP 45,899 against the type I enzyme,
and its hydrolysis was only marginally inhibited by ceftazidime and SCH 29482. Nitrocefin, when used as the enzyme-labile substrate, showed minimal inhibition for CP 45,899, a finding expected for this inhibitor from previous analyses using cephaloridine as the beta-lactamase-labile substrate. In contrast, PADAC seemed more sensitive to the inhibitory qualities of all tested beta-lactam compounds. All six inhibitors showed -75% RHR reduction at concentrations of no more than 20% of the PADAC substrate, confirming a previous report (5) .
When CENTA was added to commonly used microbiological broth media (Mueller-Hinton, brain heart infusion, Schaedler, and Trypticase soy [BBL Microbiology Systems]) no significant nonspecific (beta-lactamase-like) color change occurred as monitored by a spectrophotometer. Human serum (50%) also did not adversely affect the color reaction, as it does with nitrocefin (9) . The positive chrome-yellow reaction obtained with 25-to 50-pug/ml CENTA solutions was difficult to interpret with the unaided eye, especially in the broths that are yellowish and in human body fluids which contain yellow-colored constituents such as bilirubin. Thus, this chromogen seems most applicable to spectrophotometric analyses of beta-lactamase action. We recommend that these analyses be performed at 340 or 405 nm, preferably the latter.
In conclusion, CENTA is seen as a useful tool for detecting and measuring beta-lactamases. It is also applicable to the classification of these enzymes through the development of hydrolysis and inhibition profiles. Like its congener PA-DAC, CENTA was found to be relatively unaffected by human serum (13, 14) and was sufficiently labile to common beta-lactamases for use as an indicator reagent, particularly in instrumental analyses by non-UV range equipment. Thus, CENTA is another addition to the armamentarium of reagents capable of detecting betalactamases that can be used in the clinical microbiology laboratory.
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